Ozcelik N - Search Results

1

Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Sahin-Calapoglu N, Tan M, Soyoz M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: ozcelik n. Neuromolecular Med. 2009;11(2):106-13. doi: 10.1007/s12017-009-8062-5. Epub 2009 Apr 19. Neuromolecular Med. 2009. PMID: 19381883

2

Genetic study of demyelinating form of autosomal-recessive Charcot-Marie-tooth diseases in a Turkish family.

Sahin-Calapoglu N, Soyoz M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: ozcelik n. Int J Neurosci. 2009;119(8):1179-89. doi: 10.1080/00207450902869906. Int J Neurosci. 2009. PMID: 19922348

3

Novel human pathological mutations. Gene symbol: GDAP1. Disease: Charcot-Marie-Tooth disease 4A.

Sahin-Calapoglu N, Soyoz M, Tan M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: ozcelik n. Hum Genet. 2009 Apr;125(3):342. Hum Genet. 2009. PMID: 19320013 No abstract available.

4

Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats.

Aydin G, Ozçelik N, Ciçek E, Soyöz M. Aydin G, et al. Among authors: ozcelik n. Hum Exp Toxicol. 2003 Jul;22(7):383-91. doi: 10.1191/0960327103ht354oa. Hum Exp Toxicol. 2003. PMID: 12929728

5

Ochratoxin A reduces NMDA receptor subunits 2A and 2B concentrations in rat hippocampus: partial protective effect of melatonin.

Delibas N, Altuntas I, Yonden Z, Ozcelik N. Delibas N, et al. Among authors: ozcelik n. Hum Exp Toxicol. 2003 Jun;22(6):335-9. doi: 10.1191/0960327103ht357oa. Hum Exp Toxicol. 2003. PMID: 12856956

6

Cytogenetic abnormalities detected in patients with non-obstructive azoospermia and severe oligozoospermia.

Koşar PA, Ozçelik N, Koşar A. Koşar PA, et al. Among authors: ozcelik n. J Assist Reprod Genet. 2010 Jan;27(1):17-21. doi: 10.1007/s10815-009-9366-y. J Assist Reprod Genet. 2010. PMID: 20063119 Free PMC article.

7

Anticlastogenic effect of caffeic acid phenethyl ester on cisplatin-induced chromosome aberrations in rat bone marrow cells.

Yilmaz HR, Uz E, Altunbasak A, Sakalli E, Ozçelik N. Yilmaz HR, et al. Among authors: ozcelik n. Toxicol Ind Health. 2010 Feb;26(1):33-7. doi: 10.1177/0748233709355731. Epub 2009 Nov 23. Toxicol Ind Health. 2010. PMID: 19933724

8

The protective effect of caffeic acid phenethyl ester (CAPE) on oxidative stress in rat liver exposed to the 900 MHz electromagnetic field.

Koyu A, Ozguner F, Yilmaz H, Uz E, Cesur G, Ozcelik N. Koyu A, et al. Among authors: ozcelik n. Toxicol Ind Health. 2009 Jul;25(6):429-34. doi: 10.1177/0748233709106821. Toxicol Ind Health. 2009. PMID: 19671636

9

Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart.

Okutan H, Ozcelik N, Yilmaz HR, Uz E. Okutan H, et al. Among authors: ozcelik n. Clin Biochem. 2005 Feb;38(2):191-6. doi: 10.1016/j.clinbiochem.2004.10.003. Clin Biochem. 2005. PMID: 15642285

10

Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells.

Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbas A, Ozcelik N. Gokalp O, et al. Among authors: ozcelik n. Mol Cell Biochem. 2006 Oct;290(1-2):55-9. doi: 10.1007/s11010-006-9157-z. Epub 2006 Sep 9. Mol Cell Biochem. 2006. PMID: 16964438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results